Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eisai Inc.
Tesaro, Inc.
Merck Sharp & Dohme LLC
Hoffmann-La Roche
Seagen Inc.
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
AstraZeneca
AstraZeneca
Merck Sharp & Dohme LLC
AbbVie
AstraZeneca